SIMULATING THE IMPACT OF FIRST-LINE TREATMENT CHOICE ON SURVIVAL AMONG PATIENTS WITH LOCALLY ADVANCED/METASTATIC UROTHELIAL CARCINOMA CONSIDERED CISPLATIN INELIGIBLE Meeting Abstract
Industry Collaboration
International Collaboration